pantothenic acid Report issue

Small molecule Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
PANTOTHENIC ACID, (±)- is a racemic mixture of D-pantothenic acid and L-pantothenic acid. Only dextrorotatory isomer, also called vitamin B5, possess biological activity. Tht levorotatory form is an antagonist of D-pantothenic acid as was shown in animal experiments.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

calcium pantothenate | calc pantoth | cantopal | d-pantothenic acid | pantothenate | (+)-pantothenic acid | pantothenic acid | pantovigar | vitamin b5 | vitamin b 5

Organizations (13)

Research & Development (12)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (11)

Approved Indications (2)


 

Anemia, Pernicious (approved 1993)

Kidney Failure, Chronic

Experimental Indications - Clinical Trial Phases 1-4 (9)


 

Acne Vulgaris (Phase 1)

Alopecia (Phase 2)

Arthritis, Rheumatoid ()

Cognitive Dysfunction (Phase 2)

Dermatology (Phase 3)

Hair (Phase 4)

Ludwig's Angina (Phase 2)

Lupus Erythematosus, Systemic ()

Osteoarthritis ()

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial Organizations: 12

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue